A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than ...
It is better to get the vaccine at a younger age since it provides a stronger immune response and better protection against HPV infection. Between ages 16 to 45, three doses of vaccines are ...